Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia
2005 · BMC Psychiatry · 73 citations
https://doi.org/10.1186/1471-244x-5-3
H
Haya Ascher‐Svanum
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
233
Papers
5.6K
Citations
43
h-index
99
i10-index
Haya Ascher‐Svanum is an academic researcher from Eli Lilly (United States). The author has contributed to research in topics: Schizophrenia research and treatment & Bipolar Disorder and Treatment & Mental Health and Psychiatry. The author has an h-index of 43, co-authored 199 publications.
Papers by this author
worksCost of antipsychotic polypharmacy in the treatment of schizophrenia
2008 · BMC Psychiatry · 65 citations
https://doi.org/10.1186/1471-244x-8-19
Early Discontinuation and Restart of Insulin in the Treatment of Type 2 Diabetes Mellitus
2014 · Diabetes Therapy · 50 citations
https://doi.org/10.1007/s13300-014-0065-z
Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
2009 · BMC Psychiatry · 46 citations
https://doi.org/10.1186/1471-244x-9-54
Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis
2015 · Diabetes Therapy · 38 citations
https://doi.org/10.1007/s13300-015-0118-y
Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia
2011 · BMC Psychiatry · 29 citations
https://doi.org/10.1186/1471-244x-11-152
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat